Industry

News

February 22, 2023

The Veterans Fighting to Legalize Psychedelics

In a major shift that would modify laws set half a decade ago, states and cities around the United States are moving to legalize psychedelics for use as a medical treatment.

February 16, 2023

Twitter becomes first social media platform to allow cannabis ads in U.S.

Twitter on Wednesday became the first social media platform to allow cannabis companies to market their brands and products in the United States.The company had earlier only allowed advertising for hemp-derived CBD topical products, while other social media platforms including Facebook, Instagram and TikTok follow a "no cannabis advertising policy" as pot remains illegal at the federal level.

February 14, 2023

Schumer Meets With GOP Senators To Discuss Marijuana Legislation For New Congress

Senate Majority Leader Chuck Schumer (D-NY) held a second meeting on marijuana legislation for the new Congress on Tuesday—and this time, he convened a group of GOP senators to discuss next steps for crafting a passable bill, Senate sources tell Marijuana Moment.

January 31, 2023

How Psychedelics Can Help People, Addiction in America, and Practicing Gratitude, with Dr. Roland Griffiths

Megyn Kelly is joined by Dr. Roland Griffiths, Director of the Center for Psychedelic and Consciousness Research at the Johns Hopkins University School of Medicine, to talk about the history of psychedelic drugs and more.

January 27, 2023

A Novel Cannabinoid May Help Protect the Brain From Aging

A large variety of brain disorders associated with aging are characterized by a progressive neuronal loss, including Alzheimer’s disease and Parkinson’s disease, among others. During the past few decades, research from my laboratory on the pathological mechanism underlying these diseases has documented the critical role of long-term brain inflammation.

January 24, 2023

The FDA could approve MDMA-assisted therapy by 2024: Rick Doblin

Founder and Executive Director of MAPS Rick Doblin discusses a new study that supports the psychedelic MDMA as treatment for PTSD on 'Kennedy.'

January 16, 2023

New Study Supports MDMA As A Treatment For PTSD

A California biopharmaceutical company has announced positive results from a clinical trial testing MDMA as a treatment for post-traumatic stress disorder, bolstering its efforts to gain federal approval for the therapeutic use of the psychedelic drug also known as ecstasy.

January 13, 2023

One In Five People Who Are Ditching Alcohol For ‘Dry January’ Say They’re Using Cannabis As An Alternative, Survey Finds

About one in five people who are abstaining from alcohol as part of “Dry January” say they’re using cannabis as an alternative to help get through the month, according to a new survey. While most observers (33 percent) of the month-long alcohol break say they’re not replacing booze with anything, 21 percent said that they’re opting for cannabis and CBD products, the poll from CivicScience found.

January 3, 2023

Legal Use of Hallucinogenic Mushrooms Begins in Oregon

On Jan. 1, Oregon became the first state to allow adult use of psilocybin “magic” mushrooms. Licensed guides will likely determine whether the program is a success.

December 18, 2022

Drug Companies Join Medical Psychedelic Movement—but Without the High

Mind-bending psychedelics including MDMA (aka “ecstasy”), “magic mushrooms” and LSD are being studied as potential treatments for depression, post-traumatic stress disorder and addiction.

November 8, 2022

What Promise Do Psychedelics Hold as Therapeutics?

When psychedelics were first studied more than 50 years ago, researchers noticed that they were useful in helping people explore a greater sense of self. Now, after a half-century hiatus, scientists are studying psychedelics like MDMA, psilocybin, and ketamine as treatment for depression, PTSD, anxiety, and other mental health conditions.

October 19, 2022

Can Psychedelics Cure?

Hallucinogenic drugs—popularly called psychedelics—have been used by human societies for thousands of years. Today, scientists are taking a second look at many of these mind-altering substances–both natural and synthetic–and discovering that they can have profoundly positive clinical impacts, helping patients struggling with a range of afflictions from addiction to depression and PTSD.

December 20, 2021

Pfizer Bets On Medical Cannabis With $6.7 Billion Acquisition

Pfizer is to enter the medical cannabis industry betting on a promising cannabinoid-based bowel disease treatment.